Published in Int J Breast Cancer on January 31, 2016
Dissecting the genomic activity of a transcriptional regulator by the integrative analysis of omics data. Sci Rep (2017) 0.75
Accelerated parallel algorithm for gene network reverse engineering. BMC Syst Biol (2017) 0.75
Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches. Oxid Med Cell Longev (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Molecular portraits of human breast tumours. Nature (2000) 94.14
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Triple-negative breast cancer. N Engl J Med (2010) 11.39
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell (2007) 8.94
The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer (2007) 8.05
Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature (1993) 7.56
Basal-like breast cancer: a critical review. J Clin Oncol (2008) 5.64
Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev (2000) 5.36
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature (2007) 5.14
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest (2004) 5.06
Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol (2005) 4.80
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 4.67
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev (2004) 3.91
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res (2005) 3.23
Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol (1997) 3.05
FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta (2006) 2.98
The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A (2002) 2.93
Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res (2006) 2.92
The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res (2006) 2.84
Forkhead box M1B transcriptional activity requires binding of Cdk-cyclin complexes for phosphorylation-dependent recruitment of p300/CBP coactivators. Mol Cell Biol (2004) 2.72
FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res (2002) 2.71
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol (2008) 2.68
The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res (1997) 2.62
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol (1986) 2.52
Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol (2004) 2.48
Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene (2009) 2.32
The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin Cancer Res (2007) 2.27
The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol (2004) 2.19
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther (2008) 2.18
The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology (2007) 1.99
FOXM1 confers acquired cisplatin resistance in breast cancer cells. Mol Cancer Res (2010) 1.95
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci (2005) 1.85
The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem (2005) 1.83
FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res (2010) 1.78
Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci U S A (2001) 1.75
Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident. Curr Biol (1998) 1.72
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol Cancer Ther (2012) 1.72
The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. J Biol Chem (2006) 1.68
FOX(M1) news--it is cancer. Mol Cancer Ther (2013) 1.64
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer (2008) 1.63
Retracted FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors. Breast Cancer Res Treat (2009) 1.57
Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology (2012) 1.53
p53 negatively regulates expression of FoxM1. Cell Cycle (2009) 1.49
A new target for proteasome inhibitors: FoxM1. Expert Opin Investig Drugs (2010) 1.48
FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One (2009) 1.48
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol (2009) 1.46
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. J Clin Invest (2014) 1.45
Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med (2010) 1.43
FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene (2010) 1.34
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther (2011) 1.32
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biol (2013) 1.31
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. Breast Cancer Res (2008) 1.30
Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell (2014) 1.26
The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. Genomics (1997) 1.24
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. Oncogene (2011) 1.24
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis (2012) 1.22
Discovery of a biologically active thiostrepton fragment. J Am Chem Soc (2005) 1.20
Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer (2010) 1.16
New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast. J Pathol (2007) 1.11
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance. Oncogene (2013) 1.11
Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis. Breast Cancer Res (2011) 1.10
FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer. Cancer Lett (2013) 1.08
FoxM1 regulates mammary luminal cell fate. Cell Rep (2012) 1.08
Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene (2000) 1.07
Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nat Commun (2014) 1.05
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene (2015) 1.04
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife (2014) 1.03
Triple-negative breast cancer: current state of the art. Tumori (2011) 1.03
The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA. Oncotarget (2011) 1.00
The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. Mol Cancer Res (2012) 0.98
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway. Oncotarget (2015) 0.98
Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer. Cancer Gene Ther (2013) 0.94
The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett (2006) 0.93
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Res (2014) 0.93
Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer (2011) 0.92
ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer. Am J Pathol (2011) 0.88
Prognostic discrimination using a 70-gene signature among patients with estrogen receptor-positive breast cancer and an intermediate 21-gene recurrence score. Int J Mol Sci (2013) 0.86
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells. Int J Mol Sci (2014) 0.86
FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance. Cell Signal (2015) 0.84
Regulation of the FOXM1 transcription factor by the estrogen receptor alpha at the protein level, in breast cancer. Hippokratia (2006) 0.84
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer. PLoS One (2014) 0.84
FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci (2015) 0.84
MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1. Mol Med Rep (2015) 0.82
Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer. J Korean Med Sci (2015) 0.79
Casticin induces breast cancer cell apoptosis by inhibiting the expression of forkhead box protein M1. Oncol Lett (2014) 0.76